Introduction: The development of a fistula and/or an abscess are major complications in patients with Crohn’s disease. An abscess can involve any of the major viscera, including the liver and spleen. Case Report: A 27-year-old male patient with a 6-month history of NOD2/CARD15-positive Crohn’s disease with stenosis of the terminal ileum, previously treated with corticosteroids, was admitted with fever, chills, diarrhea, fatigue and cachexia. Diagnostic work-up revealed sepsis, an abscess in the right hepatic lobe, multiple abdominal collections and right-sided pleural effusion. It was felt that his poor general condition prevented surgical intervention and complex conservative treatment was initiated. It consisted of total parenteral nutrition, antibiotics, percutaneous drainage of the liver abscess, and thoracocentesis. Pus and blood cultures showed Lactobacillus acidophilus. There was a gradual improvement in the patient’s condition and the liver abscess decreased in diameter from 14 to 2 cm. Aminosalicylates and enteral nutrition were gradually introduced. The patient was discharged after 9 weeks in good general condition. Conclusion: Although extremely rarely, L. acidophilus can cause hepatic abscess and sepsis. This can be explained by immunologic incompetence due to corticosteroid treatment of Crohn’s disease.

Journal Section:
Case Report
Keywords:
Lactobacillus acidophilus, Liver abscess, Crohn’s disease, NOD2/CARD15 mutation, Corticosteroids
1.
Antony S, Stratton CW, Dummer JS: Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 1996;23:773–778.
[PubMed]
2.
Kunz AN, Noel JM, Fairchok MP: Two Cases of Lactobacillus bacteriemia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004;38:457–458.
[PubMed]
https://doi.org/10.1097%2F00005176-200404000-00017
3.
Green M, Barbadora K, Michaels M: Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol 1991;29:2503–2506.
[PubMed]
4.
Vakil N, Hayne G, Sharma A, et al: Liver abscess in Crohn’s disease. Am J Gastroenterol 1994;89:1090–1095.
[PubMed]
5.
Cooper C, Vincent A, Greene JN, et al: Lactobacillus bacteremia in febrile neutropenic patients in a cancer hospital. Clin Infect Dis 1998;26:1247–1248.
[PubMed]
https://doi.org/10.1086%2F513955
6.
Horwitch CA, Furseth HA, Larson AM, et al: Lactobacillemia in three patients with AIDS. Clin Infect Dis 1995;21:1460–1462.
[PubMed]
7.
Husni R, Gordon SM, Washington JA, et al: Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997;25:1048–1055.
[PubMed]
https://doi.org/10.1086%2F516109
8.
Olano A, Chua J, Schroeder S, et al: Weissella confusa (Basonym: Lactobacillus confusus) bacteremia: a case report. J Clin Microbiol 2001;39:1604–1607.
[PubMed]
https://doi.org/10.1128%2FJCM.39.4.1604-1607.2001
9.
Haller D, Jobin C: Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr 2004;38:123–136.
[PubMed]
https://doi.org/10.1097%2F00005176-200402000-00004
10.
Janeway CA Jr: How the immune system protects the host from infection. Microbes Infect 2001;3:1167–1171.
[PubMed]
https://doi.org/10.1016%2FS1286-4579%2801%2901477-0
11.
Duchmann R, May E, Heike M, et al: T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens form resident intestinal flora in humans. Gut 1999;44:812–818.
[PubMed]
https://doi.org/10.1136%2Fgut.44.6.812
12.
Bonen DK, Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521–536.
[PubMed]
https://doi.org/10.1053%2Fgast.2003.50045
13.
Schultsz C, Van Den Berg F, Ten Kate FW, et al: The intestinal mucus layer from patients with inflammatory bowel disease harbours high numbers of bacteria compared with controls. Gastroenterology 1999;117:1089–1097.
[PubMed]
https://doi.org/10.1016%2FS0016-5085%2899%2970393-8
14.
Gionchetti P, Rizzello F, Helwig U, et al: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003;124:1202–1209.
[PubMed]
https://doi.org/10.1016%2FS0016-5085%2803%2900171-9
15.
Shanahan F: Host-flora interactions in inflammatory bowel disease. Inflamm Bowel Dis 2004;10:S16–S24.
https://doi.org/10.1097%2F00054725-200402001-00004
© 2006 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2006
You do not currently have access to this content.